Products Remdesivir is commercially available as a powder for a concentrate for the preparation of an infusion solution (Veklury, Gilead Sciences Inc, USA). Provisional approval was granted in many countries and in the EU in July 2020. On November 25, 2020, the approval will be granted. In the U.S., the drug was registered in October. … Remdesivir
A nucleoside always consists of a nucleic base linked to the monosaccharide ribose or deoxyribose by an N-glycosidic bond. All 5 nucleic bases – the building blocks of DNA and RNA double and single helices – can be enzymatically converted into nucleosides. Some glycosides have physiological significance such as adenosine, which is the basic building … Nucleosides: Function & Diseases
